This Could Be a New Billion-Dollar Market for Moderna

In this Motley Fool Live video recorded on March 26, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss Moderna's (NASDAQ: MRNA) coronavirus vaccine trial in kids -- and what that population may mean for revenue.

Continue reading

Source Fool.com